Relapsed Leukemia and Lymphoma Program News and Updates
FDA Approves Personalized Cellular Therapy for Advanced Leukemia Developed by University of Pennsylvania and Children’s Hospital of Philadelphia
This is a game changer for the treatment of pediatric patients battling leukemia and a pivotal milestone in this fresh era of cellular therapies that treat cancer with a patient`s own immune system.
FDA Committee Recommends Approving Very first Cell Therapy to Successfully Treat Cancer
The experimental, personalized cell therapy that amps up the patient’s own immune system has passed a critical milestone in the path to utter FDA approval.
Five Years Later, Very first Pediatric Recipient of CAR T-Cell Therapy Remains Cancer-free
Five years after her T-cell therapy for ALL, Emily remains cancer-free. CHOP has since treated more than one hundred seventy patients in clinical trials that have seen a 93% remission rate.
Exploring CAR T-cell Therapy
Published on Jan Legal, two thousand seventeen in CHOP News
Dr. Grupp explains why CAR T-cell therapy is such a critical contraption for treating relapsed pediatric leukemia and how this revolutionary treatment works.
Experimental Cancer Therapy Saves Lives at CHOP, up for FDA Approval
Published on Jan Ten, two thousand seventeen in CHOP News
The experimental CAR T-cell therapy is up for FDA approval this year, and if approved, has the potential to help more leukemia patients.
CHOP Leukemia Discovery Prepares to Go Global
Children around the world may one day be able to receive T-cell therapy closer to home.
In Clinical Trials, CAR T Cell Immunotherapy Proceeds to Yield Finish Responses in Children & Youthful Adults with Relapsed and Refractory Leukemia
Published on Dec 05, two thousand sixteen in CHOP News
An innovative therapy using a patient`s own immune cells resumes to demonstrate results in a high-risk type of acute lymphoblastic leukemia.
Stand Up two Cancer Features Mitch Carbon’s Immunotherapy Story
Published on Sep 27, two thousand sixteen in CHOP News
After four years of battling leukemia, Mitch was no longer responding to his cancer therapy. But fresh immunotherapy options at Children’s Hospital gave him another chance to be a kid.
CHOP Patient Featured in the American Association for Cancer Research two thousand sixteen Cancer Progress Report
Published on Sep 21, two thousand sixteen in CHOP News
Diagnosed with acute lymphoblastic leukemia (ALL) just before his 12th bday, Luke Theodosiades` parents turned to investigational treatments at CHOP. This is his story.
CHOP Oncologist Receives $1 Million Hyundai Quantum Grant to Improve Leukemia Treatment
Published on Mar 30, two thousand sixteen in CHOP News
Dr. Richard Aplenc has received a $1 million Hyundai Quantum Grant from Hyundai Hope on Wheels to advance treatment for a high-risk form of childhood leukemia